Here are relevant reports on : clinical-trial-imaging-market

• Clinical Trial Packaging Market - Global Forecast to 2024

  This study will involve the extensive use of both primary and secondary sources. The research process will involve the study of various factors affecting the industry, to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029

  The global clinical trial imaging market, valued at US$1.32 billion in 2023, stood at US$1.42 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$2.07 billion by the end of the period. The increase in R&D spending, growth in the pharmaceutical and biotechnology industry and the increasing number of CROs are driving the clinical trial imaging market.

  • Published: October 2024
  • Price: $ 4950
  • TOC Available:

• Healthcare BPO Market by Life Science (Drug Discovery, Clinical Trial, Regulatory), Provider (RCM, Clinical Documentation, Patient Engagement), Payer (Billing, Claims), Technology (BPaaS, AI-enabled), Model (Onshore, Offshore) - Global Forecast to 2031

  The global healthcare BPO market is projected to reach USD 735.05 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: July 2026
  • Price: $ 4950
  • TOC Available:

• Medical Imaging Workstations Market by Component (CPU, Hardware, Image Software), Modality (CT, MRI, Mammography), Application (Clinical Review, Diagnostic Imaging, 3D Imaging), Specialty, and Region - Global Forecasts to 2023

  The medical imaging workstations market is projected to reach USD 1,377 million by 2023, growing at a CAGR of 8.9%. Factors such as the rising global burden of target diseases, increased product commercialization, rising public-private investments to support product development, evolving user preference for digital platforms, and the establishment of new medical facilities are driving the growth of the global medical imaging workstations market. General Electric Company (US), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Carestream Health (US), Hologic (US), Carl Zeiss Meditec AG (Germany), Accuray Incorporated (US), Capsa Healthcare (US), Ampronix (US), Medicor Imaging (US), NGI Group (France), Alma IT Systems (Spain), and Pie Medical Imaging (Netherlands) are some of the major players operating in the global medical imaging workstations market.

  • Published: January 2019
  • Price: $ 4950
  • TOC Available:

• Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) & Region - Global Forecast to 2025

  The global clinical trial management system market growth is primed to transition from $801 million in 2020 to $1.59 billion by 2025, showcasing a strong CAGR of 14.7%. The growth of this market is driven by the increasing number of clinical trials and government support for research trials. However, budget constraints and limited knowledge about advanced CTMS solutions restrain the market's growth.

  • Published: January 2021
  • Price: $ 4950
  • TOC Available:

• Clinical Trial Services Market by Type (Lab, Monitoring, Contracts, Recruitment, PV, Biostatistics), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global forecast to 2031

  The global clinical trial services market is projected to reach USD 97.41 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• Pharmaceutical Quality Management Software (QMS) Market by Process (Clinical Trial, Regulatory, Manufacturing, Commercialization), Application (eSOP, CAPA, Compliance), Size (Large, Small), End User (pharma, biotech, CRO), Region - Global Forecast to 2030

  The global pharmaceutical quality management software market is projected to reach USD 2.98 billion by 2030 from USD 1.59 billion in 2025, at a high CAGR of 13.3% during the forecast period.

  • Published: November 2025
  • Price: $ 4950
  • TOC Available:

• Clinical Trial Supplies Market by Service [Manufacturing, Packaging (Primary, Secondary), Logistics], Phases, Type (Small Molecules, Biologics, Vaccine), Therapeutic Areas (Oncology, Neurology, Ophthalmology, Dermatology), Region - Global Forecast to 2031

  The global clinical trial supplies market is projected to reach USD 8.95 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: October 2026
  • Price: $ 4950
  • TOC Available:

• Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021

  Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.

  • Published: February 2017
  • Price: $ 4950
  • TOC Available:

• Healthcare IoT Market by Usage (Embedded System, Wireless Network), Product (Monitoring & Notification System, Software), End User (Hospital, Academia, Government), Application (Telemedicine, Clinical Trial, Asset Management)- Global Forecasts to 2019

  Emerging markets including Middle East, China, India, Mexico, and Brazil have become attractive destinations for companies engaged in the development and distribution of healthcare IoT products. A number of factors such as growing adoption of cloud-based and mobile healthcare technologies in emerging countries, rising medical tourism due to low cost healthcare facilities, and expansion of healthcare infrastructure across emerging countries (especially in rural areas) are offering high growth opportunities for players active in the global healthcare IoT market.

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• NEXT
• LAST

Records 1 to 10 of 50